Dr. Chris Ryerson is a Professor of Medicine at the University of British Columbia and Head of the Division of Respiratory Medicine at Providence Health Care in Vancouver, Canada. His research focuses on the diagnosis, management, and prognostication of pulmonary fibrosis, with much of this work done using the Canadian Registry for Pulmonary Fibrosis, which he leads. He has also led several national and international clinical practice guidelines on the diagnosis and management of pulmonary fibrosis.
The concepts advanced by REMAP-ILD are the way of future. All future clinical trials should be incorporating these approaches and the sooner we all start doing so, the better it will be for the patients who need more and better treatment options. Dr. Chris Ryerson
The concepts advanced by REMAP-ILD are the way of future. All future clinical trials should be incorporating these approaches and the sooner we all start doing so, the better it will be for the patients who need more and better treatment options.
Dr. Chris Ryerson